Elevated ceramide levels disrupt insulin signaling pathways, induce β‐cell apoptosis, and fuel inflammation, core features of glucolipotoxicity and key pathophysiological hallmarks of T2D [152]. This evidence concerns the gene INS and type 2 diabetes mellitus.